AR021475A1 - Procedimiento para preparar sales de trovafloxacina de adicion de acidos y compuestos intermediarios de uso exclusivo en dicho procedimiento - Google Patents
Procedimiento para preparar sales de trovafloxacina de adicion de acidos y compuestos intermediarios de uso exclusivo en dicho procedimientoInfo
- Publication number
- AR021475A1 AR021475A1 ARP990104424A ARP990104424A AR021475A1 AR 021475 A1 AR021475 A1 AR 021475A1 AR P990104424 A ARP990104424 A AR P990104424A AR P990104424 A ARP990104424 A AR P990104424A AR 021475 A1 AR021475 A1 AR 021475A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- salts
- acids
- intermediate compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se preparan sales de trovafloxacina de adicion de ácidos de formula (1) en la que ZH es un ácido mineral, caracterizado porque comprende las etapas deponer en contacto un compuesto de formula (2) en la que R es un grupo alquilo C1-6 y donde el anillode bencilideno del compuesto de formula (2) estásustituido opcionalmente con al menos un grupo fluor, cloro, bromo, yodo, alquilo C1-6 o alcoxi C1-6, con una composicion que comprende el ácido mineral ZH yagua. Como ácidos minerales se incluyen, sincarácter limitativo, los ácidos metano, etano y bencenosulfonico; ácido nítrico, sulfurico, fosforico, clorhídrico, bromhídrico, tartárico, cítrico, acético y maleico. Dichas sales son de aplicacion como agentes antibioticos. Se definen otros procedimientos de preparacionque figuran en la memoria. También se reivindican compuestos intermediarios de aplicacion exclusiva en la preparacion de dichas sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9894498P | 1998-09-03 | 1998-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR021475A1 true AR021475A1 (es) | 2002-07-24 |
Family
ID=22271674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990104424A AR021475A1 (es) | 1998-09-03 | 1999-09-02 | Procedimiento para preparar sales de trovafloxacina de adicion de acidos y compuestos intermediarios de uso exclusivo en dicho procedimiento |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US6359137B1 (es) |
| EP (1) | EP0989119A1 (es) |
| JP (1) | JP3354526B2 (es) |
| KR (1) | KR20000022858A (es) |
| CN (1) | CN1248580A (es) |
| AP (1) | AP1118A (es) |
| AR (1) | AR021475A1 (es) |
| AU (1) | AU761035B2 (es) |
| BG (1) | BG103703A (es) |
| BR (1) | BR9904082A (es) |
| CA (1) | CA2281244C (es) |
| CO (1) | CO5251466A1 (es) |
| EA (1) | EA002340B1 (es) |
| EE (1) | EE04118B1 (es) |
| GE (1) | GEP20022785B (es) |
| GT (1) | GT199900142A (es) |
| HN (1) | HN1999000141A (es) |
| HR (1) | HRP990274A2 (es) |
| HU (1) | HUP9902967A3 (es) |
| ID (1) | ID23718A (es) |
| IL (1) | IL131614A0 (es) |
| IN (1) | IN191583B (es) |
| IS (1) | IS5168A (es) |
| MA (1) | MA24966A1 (es) |
| MY (1) | MY130800A (es) |
| NO (1) | NO994261L (es) |
| NZ (1) | NZ337605A (es) |
| OA (1) | OA11152A (es) |
| PA (1) | PA8481001A1 (es) |
| PE (1) | PE20001026A1 (es) |
| PL (1) | PL335246A1 (es) |
| SG (1) | SG74748A1 (es) |
| SK (1) | SK116599A3 (es) |
| SV (1) | SV1999000144A (es) |
| TN (1) | TNSN99164A1 (es) |
| TR (1) | TR199902138A2 (es) |
| TW (1) | TW520369B (es) |
| UY (1) | UY25686A1 (es) |
| YU (1) | YU43199A (es) |
| ZA (1) | ZA995630B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104892507B (zh) * | 2015-05-26 | 2018-08-28 | 徐州天意动物药业股份有限公司 | 水溶性甲磺酸沙拉沙星及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164402A (en) * | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
| WO1995019361A1 (en) * | 1994-01-18 | 1995-07-20 | Pfizer Inc. | Process and intermediates for preparing naphthyridonecarboxylic acid salts |
| EP0789697B1 (en) * | 1995-06-06 | 1998-06-17 | Pfizer Inc. | CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT |
| JPH0912547A (ja) * | 1995-06-23 | 1997-01-14 | Chisso Corp | ニューキノロン系化合物中間体の製造方法 |
| JPH0912546A (ja) * | 1995-06-23 | 1997-01-14 | Chisso Corp | アザビシクロ環化合物および製造方法 |
| WO1997007800A1 (en) * | 1995-08-29 | 1997-03-06 | Pfizer Inc. | Zwitterionic forms of trovafloxacin |
| PA8464701A1 (es) * | 1998-01-16 | 2000-09-29 | Pfizer Prod Inc | Procedimiento e intermedios para preparar naftiridonas |
| US6184380B1 (en) * | 1999-01-25 | 2001-02-06 | Pfizer Inc. | Process for preparing naphthyridones and intermediates |
-
1999
- 1999-08-17 HN HN1999000141A patent/HN1999000141A/es unknown
- 1999-08-25 GT GT199900142A patent/GT199900142A/es unknown
- 1999-08-25 SK SK1165-99A patent/SK116599A3/sk unknown
- 1999-08-26 US US09/383,320 patent/US6359137B1/en not_active Expired - Fee Related
- 1999-08-26 IL IL13161499A patent/IL131614A0/xx unknown
- 1999-08-27 AU AU44826/99A patent/AU761035B2/en not_active Ceased
- 1999-08-30 TW TW088114861A patent/TW520369B/zh active
- 1999-08-30 IS IS5168A patent/IS5168A/is unknown
- 1999-08-31 OA OA9900199A patent/OA11152A/en unknown
- 1999-08-31 PA PA19998481001A patent/PA8481001A1/es unknown
- 1999-08-31 UY UY25686A patent/UY25686A1/es not_active Application Discontinuation
- 1999-09-01 PE PE1999000878A patent/PE20001026A1/es not_active Application Discontinuation
- 1999-09-01 MA MA25749A patent/MA24966A1/fr unknown
- 1999-09-01 IN IN1171DE1999 patent/IN191583B/en unknown
- 1999-09-01 EP EP99306947A patent/EP0989119A1/en not_active Withdrawn
- 1999-09-01 ZA ZA9905630A patent/ZA995630B/xx unknown
- 1999-09-01 TN TNTNSN99164A patent/TNSN99164A1/fr unknown
- 1999-09-01 SG SG1999004240A patent/SG74748A1/en unknown
- 1999-09-01 BG BG103703A patent/BG103703A/bg unknown
- 1999-09-01 EA EA199900708A patent/EA002340B1/ru not_active IP Right Cessation
- 1999-09-01 CA CA002281244A patent/CA2281244C/en not_active Expired - Fee Related
- 1999-09-01 MY MYPI99003775A patent/MY130800A/en unknown
- 1999-09-01 JP JP24737399A patent/JP3354526B2/ja not_active Expired - Fee Related
- 1999-09-02 CN CN99118470A patent/CN1248580A/zh active Pending
- 1999-09-02 NO NO994261A patent/NO994261L/no unknown
- 1999-09-02 EE EEP199900457A patent/EE04118B1/xx not_active IP Right Cessation
- 1999-09-02 ID IDP990831D patent/ID23718A/id unknown
- 1999-09-02 SV SV1999000144A patent/SV1999000144A/es not_active Application Discontinuation
- 1999-09-02 YU YU43199A patent/YU43199A/sh unknown
- 1999-09-02 KR KR1019990037060A patent/KR20000022858A/ko active IP Right Grant
- 1999-09-02 TR TR1999/02138A patent/TR199902138A2/xx unknown
- 1999-09-02 NZ NZ337605A patent/NZ337605A/xx unknown
- 1999-09-02 AP APAP/P/1999/001667A patent/AP1118A/en active
- 1999-09-02 HU HU9902967A patent/HUP9902967A3/hu unknown
- 1999-09-02 AR ARP990104424A patent/AR021475A1/es unknown
- 1999-09-03 BR BR9904082-4A patent/BR9904082A/pt not_active Application Discontinuation
- 1999-09-03 PL PL99335246A patent/PL335246A1/xx not_active Application Discontinuation
- 1999-09-03 GE GEAP19994978A patent/GEP20022785B/en unknown
- 1999-09-03 HR HR990274A patent/HRP990274A2/hr not_active Application Discontinuation
- 1999-09-03 CO CO99055924A patent/CO5251466A1/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR072331A2 (es) | Derivados de acido mandelico, formulacion farmaceutica, procesos para la preparacion de estos derivados, y compuestos intermediarios | |
| EA200300619A1 (ru) | Серотонинергические средства | |
| BRPI0407672A (pt) | processos para preparar imatinib e um sal de adição ácida deste, sais de adição ácida de imatinib, composição farmaceuticamente aceitável deste, imatinib e uso deste | |
| BR9915381A (pt) | Uso de um composto, e, composto | |
| EA200201179A1 (ru) | Производные 2-аминокарбонил-9h-пурина | |
| PE20030612A1 (es) | Benzoimidazoles | |
| EA200400491A1 (ru) | Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции | |
| EA200800294A1 (ru) | Способы нейропротекции | |
| EA200000804A1 (ru) | Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина | |
| ECSP056059A (es) | Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas | |
| AR033426A1 (es) | Uso de compuestos carbamatos en la prevencion o el tratamiento de trastornos de movimiento | |
| ECSP088172A (es) | Metodos para tratar la epileptogenesis | |
| PA8561501A1 (es) | Lactamas como antagonistas de taquiquininas | |
| AR064241A1 (es) | Metodos para el tratamiento de la depresion | |
| PA8542901A1 (es) | Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple | |
| AR033427A1 (es) | Uso de compuestos carbamatos en el tratamiento del dolor | |
| AR027399A1 (es) | Compuestos heterociclicos utiles como inhibidores de la fosfodiesterasa iv, composiciones formuladas con dichos compuestos y uso de dichos compuestos parapreparar dichas composiciones | |
| EA200200489A1 (ru) | Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции | |
| BR0207644A (pt) | Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar | |
| AR021475A1 (es) | Procedimiento para preparar sales de trovafloxacina de adicion de acidos y compuestos intermediarios de uso exclusivo en dicho procedimiento | |
| EA199700030A2 (ru) | Новые производные 2,3-бензодиазепина | |
| BR0207830A (pt) | Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade | |
| PE20020551A1 (es) | Proceso para preparar derivados de distamicina | |
| EA200101113A1 (ru) | Способ получения 2-(n-фениламино) бензойных кислот | |
| AR005545A1 (es) | Un procedimiento para la preparacion de derivados de imidazodiacepina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |